Saturday, April 27, 2024
HomeArchitectureSCHOTT Pharma to build $371 million prefillable syringe manufacturing facility in North...

SCHOTT Pharma to build $371 million prefillable syringe manufacturing facility in North Carolina

DCR staff writer

SCHOTT Pharma USA, a manufacturer in the pharmaceutical and biotech industry, will establish a new production facility in Wilson County, creating 401 jobs, North Carolina Gov. Roy Cooper has announced.

The company will invest $371 million in the City of Wilson.

SCHOTT Pharma, a part of the SCHOTT Group, manufactures innovative and high-quality drug containment solutions and delivery systems for the pharmaceutical industry.

The company operates six manufacturing facilities and a corporate headquarters in the U.S. and the Wilson County site will be the first to manufacture high-performance, pre-fillable polymer syringes while simultaneously adding to the nation’s limited pool of pre-fillable glass syringes. This project will expand the domestic supply chain for these in-demand syringes.

“After conducting a nationwide search for a site that would give a campus-like option, Wilson County was chosen as a primary location to support our growth in the U.S.,” said Christopher Cassidy, President of SCHOTT North America. “The local talent pool combined with the proximity to the Research Triangle area, which hosts numerous universities, pharma companies, and research institutions, are ideal factors for the future operation of the company.”

SCHOTT Pharma’s project in North Carolina will be facilitated, in part, by a Job Development Investment Grant (JDIG) approved by the state’s Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state’s economy by $1.32 billion.

“North Carolina’s pro-growth and low-tax policies, along with the $30 million investment in the new biologics training facility at Wilson Community College, are paying off for Wilson County and the BioPharma Crescent,” said N.C. Senator Buck Newton. “SCHOTT Pharma’s $371 million capital investment and 401 high-wage jobs will strengthen our local economy, and we look forward to a long and successful future for them here in Wilson.”

Partnering with the North Carolina Department of Commerce and the Economic Development Partnership of North Carolina on this project were the North Carolina General Assembly, the North Carolina Community College System, Commerce’s Division of Workforce Solutions, Wilson County, the City of Wilson, and the Wilson Economic Development Council.

RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments